Browsing byAuthorHaddadi, N
Showing results 1 to 9 of 9
Issue Date | Title | Author(s) |
2022 | Expression Profile of Sphingosine Kinase 1 Isoforms in Human Cancer Tissues and Cells: Importance and Clinical Relevance of the Neglected 1b-Isoform. | Chen, H; Haddadi, N; Zhu, X; Hatoum, D; Chen, S; Nassif, NT; Lin, Y; McGowan, EM |
2021-07-07 | Studying the Oncosuppressive Functions of PTENP1 as a ceRNA | Travis, G; Haddadi, N; Simpson, A; Marsh, D; McGowan, E; Nassif, N; Poliseno, L |
2021-01 | Studying the Oncosuppressive Functions of PTENP1 as a ceRNA. | Travis, G; Haddadi, N; Simpson, AM; Marsh, DJ; McGowan, EM; Nassif, NT |
2019-10-15 | Toward Systems Pathology for PTEN Diagnostics. | Haddadi, N; Travis, G; Nassif, NT; Simpson, AM; Marsh, DJ |
2018-02-19 | PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy | Haddadi, N; Lin, Y; Travis, G; Simpson, AM; McGowan, EM; Nassif, NT |
2017-09-02 | “Dicing and splicing” sphingosine kinase and relevance to cancer | Haddadi, N; Lin, Y; Simpson, AM; Nassif, NT; McGowan, EM |
2017-01-01 | Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: Challenges for SphK as an oncotarget | Hatoum, D; Haddadi, N; Lin, Y; Nassif, NT; McGowan, EM |
2017 | Cancer-associated PTEN mutations alter PTEN cellular function. | Haddadi, N; McGowan, E; Nassif, N |
2015-11-25 | Determining the Frequency and Involvment of PTEN Pseudogene (PTENP1) Expression in Cancer | Haddadi, N; McGowan, E; Nassif, N |